AssureRx Health Inc., which sells a genetic test that helps doctors pick the right psychiatric drugs for patients based on their genes, has appointed a chief operating officer.

In addition to leading the personalized medicine developer’s operations, Donald Wright Jr. will manage product development, information technology and external relationships, according to the company.

The Mason, Ohio-based company credited Wright with being “instrumental” in developing its GeneSightRx test, which uses a cheek swab, mathematical algorithms and bioinformatics to narrow drug choices to those that work with a patient’s genes. The company launched the test in 2009.

Future products from AssureRx might include tests that help doctors choose medications for patients who have neuro-degenerative diseases like Alzheimer’s or Parkinson’s, as well as disorders such as attention-deficit hyperactivity and post-traumatic stress.

The company also named John Bellano as senior vice president of sales and commercial programs, according to the company.